Participants 103 122 4
suppressed patients
Participants 320 399 4
virologically suppressed patients (HIV-1 RNA <400 copies/mL for > or =3 months)
Participants 400 439 4
on stable (> or =6 months) therapy with
Participants 520 602 9
Eighty-nine suppressed patients > or =18 years old with CD4 counts >50 cells/mm(3)
Participants 1576 1694 3
Patients who experience virologic suppression with a regimen of lamivudine 150 mg BID in combination with stavudine/PI
